Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy

BACKGROUND: Cenobamate is newly approved for partial-onset seizures in adults, albeit the mechanism of its action remain poorly understood. METHODS:  This article aims to review the efficacy, safety, and tolerability of cenobamate in treating partial-onset seizures. DATA COLLECTION: The English lang...

Descripción completa

Detalles Bibliográficos
Autor principal: Singh, Alok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905054/
https://www.ncbi.nlm.nih.gov/pubmed/35282314
http://dx.doi.org/10.1177/11795735211070209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905054/
https://www.ncbi.nlm.nih.gov/pubmed/35282314
http://dx.doi.org/10.1177/11795735211070209

Ejemplares similares